EBOS Group (EBOSF) Stock Price, News & Analysis

Company Overview

EBOS Group Limited is a trans-Tasman healthcare and animal-care company serving customers in New Zealand and Australia. Its healthcare operations distribute prescription medicines, over-the-counter products, medical supplies and other healthcare products to community pharmacies, hospitals, aged-care facilities and other health providers.

The company operates through businesses including EBOS Healthcare in New Zealand and Symbion in Australia, as well as pharmacy-support and contract-logistics activities. Its services include pharmaceutical wholesaling, supply-chain management, specialty distribution and related support for healthcare suppliers and providers.

EBOS also has a substantial animal-care business, supplying veterinary practices, retailers and pet owners with veterinary medicines, animal-health products, pet food and related merchandise. Brands and businesses associated with this segment include Black Hawk, Masterpet and Lyppard.

Founded in New Zealand in 1922, EBOS expanded its regional presence through organic growth and acquisitions, including the purchase of the Australian pharmaceutical-distribution business Symbion in 2013. The group is headquartered in Christchurch, New Zealand, and is led by Group Chief Executive Officer Patrick Davies.

Key Stats

• Today's Range: $23.35 to $23.75
• 50-Day Range: $23.75 to $23.75
• 52-Week Range: $20.02 to $23.75
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EBOSF
• CIK: 1533082
• Web: www.ebosgroup.com
• Phone: 61-3-9918-5555
• Fax: N/A
• Employees: 5,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A